U.S. Self-injections Market to 2032
Overview
The U.S. Self-injections Market is expected to reach a 38.60 USD Billion by 2032 and is projected to grow at a CAGR of 11.85% from 2025 to 2032.
Revenue, 2024 (USD Billion)
17.63
Forecast, 2032 (USD Billion)
38.60
CAGR, 2024 - 2032
11.85%
Report Coverage
U.S.
U.S. Self-injections Market 2018-2032 USD Billion
U.S. Self-injections Market, Key Findings (2025-2032)
Market Growth and Projections:
- Market Size (2024): 17.63 USD Billion
- Projected Market Size (2032): 38.60 USD Billion
- CAGR (2025-2032): 11.85%
Key Findings of U.S. Self-injections Market
- The U.S. Self-injections Market was valued at 17.63 USD Billion in 2024.
- The U.S. Self-injections Market is likely to grow at a CAGR of 11.85% during the forecast period of 2024 to 2032.
- In 2024, the Largest segment Subcutaneous in Route of Administration Segment accounted for the largest share of the market with a revenue of 15.10 USD Billion
- The fastest growing segment Autoimmune Diseases in Application Segment grew Fastest with a CAGR of 12.94% during the forecast period from 2024 to 2032.
U.S. Self-injections Market Scope
U.S. Self-injections Market Segmentation & Scope
Distribution Channel
- Others
- Online Pharmacy
- Hospital Pharmacy
- Direct Tender
Gender
- Female
- Male
Age Group
- Pediatric
- Geriatric
- Adult
Application
- Others
- Hormonal Disorders
- Oncology
- Emergency Drugs
- Pain Management
- Autoimmune Diseases
Route of Administration
- Others
- Intra muscular
- Subcutaneous
Dosage Form
- Multi-Dose
- Single Dose
Product Type
- Self-Injection Formulation
- Self-Injection Devices
U.S. Self-injections Market Data Coverage Insights
| Study Period | 2024-2032 |
| Base Year | 2023 |
| Unit | Revenue in USD Billion |
| Market Value in 2024 | 17.63 USD Billion |
| Market Value in 2032 | 38.60 USD Billion |
| CAGR (2025-2032) | 11.85% |
| Historic Data | 2016-2023 |
| Market Segments Covered | Distribution Channel,Gender,Age Group,Application,Route of Administration,Dosage Form,Product Type |
Regional Insights:
-
Leading Market (2024-2032): U.S., leading in terms of revenue 17.63 USD Billion in 2024
- Key Country: U.S., leading in terms of revenue with value of 17,630.16 USD Million in 2024.
Segments and Scope
-
U.S. Self-injections Market to 2032, By Distribution Channel
- Direct Tender is the largest segment in U.S. Self-injections Market to 2032 with a revenue of 9.21 USD Billion in the year 2024.
- Direct Tender is the Fastest growing segment in U.S. Self-injections Market to 2032 with a Growth rate of 12.37 % in forecast period 2025-2032.
-
U.S. Self-injections Market to 2032, By Gender
- Male is the largest segment in U.S. Self-injections Market to 2032 with a revenue of 10.38 USD Billion in the year 2024.
- Male is the Fastest growing segment in U.S. Self-injections Market to 2032 with a Growth rate of 12.06 % in forecast period 2025-2032.
-
U.S. Self-injections Market to 2032, By Age Group
- Adult is the largest segment in U.S. Self-injections Market to 2032 with a revenue of 7.79 USD Billion in the year 2024.
- Adult is the Fastest growing segment in U.S. Self-injections Market to 2032 with a Growth rate of 12.34 % in forecast period 2025-2032.
-
U.S. Self-injections Market to 2032, By Application
- Autoimmune Diseases is the largest segment in U.S. Self-injections Market to 2032 with a revenue of 6.57 USD Billion in the year 2024.
- Autoimmune Diseases is the Fastest growing segment in U.S. Self-injections Market to 2032 with a Growth rate of 12.94 % in forecast period 2025-2032.
-
U.S. Self-injections Market to 2032, By Route of Administration
- Subcutaneous is the largest segment in U.S. Self-injections Market to 2032 with a revenue of 15.10 USD Billion in the year 2024.
- Subcutaneous is the Fastest growing segment in U.S. Self-injections Market to 2032 with a Growth rate of 11.91 % in forecast period 2025-2032.
-
U.S. Self-injections Market to 2032, By Dosage Form
- Single Dose is the largest segment in U.S. Self-injections Market to 2032 with a revenue of 11.21 USD Billion in the year 2024.
- Single Dose is the Fastest growing segment in U.S. Self-injections Market to 2032 with a Growth rate of 12.12 % in forecast period 2025-2032.
-
U.S. Self-injections Market to 2032, By Product Type
- Self-Injection Devices is the largest segment in U.S. Self-injections Market to 2032 with a revenue of 11.88 USD Billion in the year 2024.
- Self-Injection Formulation is the Fastest growing segment in U.S. Self-injections Market to 2032 with a Growth rate of 11.64 % in forecast period 2025-2032.
U.S. Self-injections Market Company Share Analysis
| Company Name |
|
||
| Novo Nordisk A/S | |||
| Sanofi | |||
| AbbVie Inc. | |||
| Amgen Inc. | |||
| Johnson & Johnson Private Limited | |||
U.S. Self-injections Market Geographical Sales Distribution, 2018-2032 USD Billion
U.S. Self-injections Market Company Profiling
Industry Related Reports
Frequently Asked Questions
The U.S. Self-injections Market is segmented based on Segmentation Distribution Channel,Gender,Age Group,Application,Route of Administration,Dosage Form,Product Type.
U.S. Self-injections Market was valued at USD 17.63(Revenue in USD Billion) in 2023.
U.S. Self-injections Market is projected to grow at a CAGR of 11.85% during the forecast period of 2024 to 2032.
The Subcutaneous segment is expected to dominate the U.S. Self-injections Market, holding a largest market share of 15.10 USD Billion in 2024
U.S. Self-injections Market Scope
U.S. Self-injections Market Segmentation & Scope
Distribution Channel
- Others
- Online Pharmacy
- Hospital Pharmacy
- Direct Tender
Gender
- Female
- Male
Age Group
- Pediatric
- Geriatric
- Adult
Application
- Others
- Hormonal Disorders
- Oncology
- Emergency Drugs
- Pain Management
- Autoimmune Diseases
Route of Administration
- Others
- Intra muscular
- Subcutaneous
Dosage Form
- Multi-Dose
- Single Dose
Product Type
- Self-Injection Formulation
- Self-Injection Devices
Frequently Asked Questions
The U.S. Self-injections Market is segmented based on Segmentation Distribution Channel,Gender,Age Group,Application,Route of Administration,Dosage Form,Product Type.
U.S. Self-injections Market was valued at USD 17.63(Revenue in USD Billion) in 2023.
U.S. Self-injections Market is projected to grow at a CAGR of 11.85% during the forecast period of 2024 to 2032.
The estimated market value of the U.S. Self-injections Market for final year is USD 38.60 (USD Billion).
U.S. Self-injections Market Company Profiling
Frequently Asked Questions
The U.S. Self-injections Market is segmented based on Segmentation Distribution Channel,Gender,Age Group,Application,Route of Administration,Dosage Form,Product Type.
U.S. Self-injections Market was valued at USD 17.63(Revenue in USD Billion) in 2023.
U.S. Self-injections Market is projected to grow at a CAGR of 11.85% during the forecast period of 2024 to 2032.
The estimated market value of the U.S. Self-injections Market for final year is USD 38.60 (USD Billion).
HAVE A QUESTION?
Get expert advice on the right strategy for your business at no cost. We also offer customized subscription plans and affordable discounts for startups and universities.